Healthcare

By

Bruce Kamich

 | Feb 11, 2016 | 12:27 PM EST

BMY is likely to retest the $55 level and could ease to $50, but a deeper decline does not seem imminent. 

By

Paul Price

 | Feb 11, 2016 | 8:00 AM EST

History gives a feel for whether its recent price decline makes the stock an attractive buy today.

By

Gary Morrow

 | Feb 9, 2016 | 3:21 PM EST

WBA bulls should consider it a very low risk buy between the $74.00 and $72.00 area.

By

Bruce Kamich

 | Feb 8, 2016 | 3:07 PM EST

Shares of the biopharmaceutical company appear no closer to a bottom. 

By

Bruce Kamich

 | Feb 8, 2016 | 2:43 PM EST

AZN looks vulnerable to further declines. The next downside support area and price target are the $26-$24 area. 

By

Bruce Kamich

 | Feb 8, 2016 | 1:32 PM EST

The next potential support levels are the $120 and $100 areas from 2013.

By

Bruce Kamich

 | Feb 8, 2016 | 11:46 AM EST

BMRN could re-base in the weeks and months ahead as downside looks limited. 

By

John Reese

 | Feb 8, 2016 | 6:00 AM EST

Dividend yield is the determining factor in this strategy.

By

Bret Jensen

 | Feb 7, 2016 | 12:00 PM EST

They offer impressive free cash flow, great balance sheets, evolving pipelines and nice dividend yields.

By

Cody Willard

 | Feb 4, 2016 | 4:00 PM EST

It's something we should have on our radar as yet another potential Black Swan for this market and economy. 

Judge Smails embarrassed me into writing it!

Some pretty obvious selling in the FATMAN names vs the Nasdaq futures post regular session...
You can see the time/price support on the daily chart of SPX below. It also shows you the ...

$185.80
Exhausted and a long weekend.
Column up shortly
Sold some IWM as well.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.